ALISO VIEJO, Calif. -- Bausch + Lomb, the global eye health company,
today announced that its new, state-of-the-art, combined vitrectomy and
phacoemulsification system, the Stellaris® PC (Procedural Choice) Vision Enhancement System, is now available to retinal surgeons in the United States. The Stellaris was previously introduced to cataract surgeons in 2007.
The new Stellaris PC platform provides a high-performance,
feature-rich, combined experience that leverages Bausch + Lomb’s legacy
of vitreoretinal surgical innovation with the demonstrated excellence of
the Stellaris phacoemulsification platform. The Stellaris
PC allows surgeons to have true “procedural choice” by providing the
most advanced technology for both vitreoretinal and cataract surgery in a
The Stellaris PC offers the following benefits to surgeons and their patients:
is the only vitreoretinal surgical system that comes with a dual light
source and surgeon-selected color filters that allow for differentiated
viewing designed to enhance the surgeon’s ability to see ocular tissue
better under various surgical conditions.
It allows surgeons a platform for the smallest incisions for both retinal and cataract surgeries. It is capable of 1.8 mm MICS™
phacoemulsification as well as a complement with Bausch + Lomb's
existing proprietary 25-gauge system of instruments for retinal surgery,
along with standard 23- and 20-gauge instruments.
It has light-weight, ultrahigh-speed vitrectomy probes for conventional and transconjunctival vitrectomy (TSV).
Dr. Carl Awh, a long-time advisor to Bausch + Lomb and a
private-practice physician with Tennessee Retina in Nashville, said,
“The Stellaris PC meets the needs of today’s vitreoretinal and
cataract surgeons. It allows us to perform the most advanced techniques
with an intuitive, more compact system and is ideally equipped for both
the ambulatory surgery center and the hospital operating room.”
The Stellaris PC has a small footprint and a wireless footpedal
with dual linear control for the operating room for ease of use and
maximum flexibility for surgeon and staff. These features help create
faster set-up times and less operating room congestion.
Russ Finlay, global marketing director, Vitreoretinal Business, Bausch + Lomb, noted, “The Stellaris
PC is ideally suited for surgeons in the hospital and ASCs by giving
them a product that is both advanced and intuitive. Today's surgeons
want to be confident that the technology they use will lead to improved
patient care and clinical efficiency. By listening to what surgeons
want, we have developed a product that makes sense for today's operating
room and the doctors and patients that depend on them."
The Stellaris PC replaces the Millennium® Microsurgical System.
# # #
About Bausch + Lomb
Bausch + Lomb is dedicated to bringing visionary ideas to eye
health. Its core businesses include contact lenses and lens care
products, ophthalmic surgical devices and instruments, and ophthalmic
pharmaceuticals. The Bausch + Lomb name is one of the best-known and
most respected healthcare brands in the world. Founded in 1853, the
company is headquartered in Rochester, N.Y., and employs more than
10,000 people worldwide. Its products are available in more than 100
countries. More information is available at www.bausch.com.
®/™ denote trademarks of Bausch & Lomb Incorporated.